The Founder Institute is the world’s premier startup launch program for talented entrepreneurs. If you are up to the challenge, our comprehensive step-by-step program will give you the structure, mentor support, and network of entrepreneurs you need to start an enduring company. Based in Silicon Valley and with chapters across 60 countries, the Founder Institute's mission is to "Globalize Silicon Valley" and build sustainable startup ecosystems worldwide.

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

“SevenSix is a learning and development platform to empower tennis players through their careers. It will be a holistic service, transforming data into knowledge about strengths and opportunities, to optimize how the player exercises, competes, eats, sleeps, thinks and is motivated. This is done by gathering, transforming, combining, and visualizing ALL relevant data, bridging science and technology combined with methodology and experience. ”MVBP is ready and is beeing tested on the national team of tennis and Stavanger Tennisklubb. The development is supported by Microsoft and Capgemini.SevenSix will be distributed to 100 million tennis players with membership in Tennis Federations.

Fishency Innovation can give access to the entire salmon industry to affordable equipment to count automatically sea lice in the cage. Monitoring sea lice is the key to controlling them, it is access to good decision support for optimized treatments and to a reliable tool to measure the efficiency of preventive measures and existing treatments. Today, sea lice are counted manually over 20 fish, every week, in each cage. It is labor-demanding, and the collected data are not reliable. Sustainability starts with good data.

Game-changing technology for structural integrity monitoring. The Ferrx FEMM (Ferrx ElectroMagnetic Method) has been developed and tested for 2 decades, first by SINTEF and since 2005 by Ferrx. The method has provided unique features for the condition monitoring of steel structures. Material deterioration can be directly measured and early warning of risk for fatigue can be established long before any crack is detectable. Furthermore, the same sensors can also measure changes in metal loss, and thus provide for non-intrusive monitoring of internal corrosion and erosion in pipes. During the last years, instrumentation technology has been industrialized and the first commercial systems have been delivered and installed. Different types of instrumentation systems are available both for onshore and offshore/subsea applications. The industrialization, marinization, and production of the instrumentation systems are being done in cooperation with the most specialized suppliers. Ferrx is an independent company located in Trondheim, Norway with the business idea to provide the FEMM technology for different onshore and offshore markets to monitor the actual condition of steel structures and thus prevent loss of assets and pollution of the environment. The FEMM is protected by 2 patents and all rights are vested in Ferrx. The system for riser inspection has been qualified by DNV-GL in accordance with DNV-RP-A203 Technology Qualification.

Smak av Italia har tre avdelinger i henholdsvis Sætre, Slemmestad og Oslo (Vulkan). Alle tre butikkene selger de samme økologiske, ekte og naturlige varene fra produsenter i Italia. I butikkene våre finner du alltid smaksprøver slik at alle har anledning til å smake på de nøye utvalgte varene. Vi ønsker at våre produkter skal bidra til gode måltider, både i hverdagen og til fest med rene, sunne og enkle retter. Alle varene vi selger er uten tilsetningsstoffer og produsert på en gammeldags, tradisjonell måte for å bevare det naturlige og rene. Vi er opptatt av god service og vil hjelpe til så mye vi kan! Har du spørsmål angående våre produkter, leverandører eller oppskrifter er vi alltid tilgjengelige.

Kontorhuset driver utleie av cellekontorer og plasser i åpent landskap med tilhørende fasiliteter i et profesjonelt kontorfellesskap i Drammen sentrum. Kontorhuset Bragernes har 37 moderne kontorer, free seating plasser og et stort kontor til 11 personer i 4 etasje. Vi kaller det Plug and work som betyr at du skal få ditt nøkkelkort og passord ved ankomst, koble deg på det trådløse nettet og starte jobben. Vi organiserer alt med tanke på møbler på kontoret, sosiale soner og tilstelninger, kjøkken, kopi/print og vask av lokalene. Du skal bruke all din tid på jobb og ikke små praktiske unødvendigheter i hverdagen, det tar vi oss av. Fra høsten av åpner vi Kontorhuset Strømsø, der skal vi ha ca 120 business mennesker under samme tak. Dette betyr at på Bragnernes og Strømsø vil Kontorhuset ha ca 180 mennesker som skal bygge relasjoner og skape verdier i jobben. Som leietaker i Kontorhuset får du tilgang på møterom, stillerom, vidoekonferanse, minikjøkken, kaffeautomat, kopi og print, toalettfasiliteter, garderobe og dusj. I kjeller eller bakgård kan du leie din egen parkeringsplass eller boder fra 4 til 38kvm for diverse lagring i kjelleren.  På Kontorhuset kan du ta en kopp kaffe med dine nye “kollegaer” for å dele tanker, ideer og utfordringer. Kanskje du får en advokat på den ene siden og en ingeniør på den andre? Mulighetene er mange. Tanken er at det skal skapes større verdier for deg ved å være en del av Kontorhuset.

Aqua Alarm is developing a Biological Water Alarm System (BiWAS). There are three things that make BiWAS stand out from all other comparable products: 1) It provides real-time monitoring 2) It monitors a broad spectrum of toxicants, carcinogens and pathogens 3) It does this in a very cost-effective way We have among other things been through the av Horizon 2020 phase 1 project and are presently performing two projects to prove the technology in real environments. We are interested in industrial and development partners.

- an easy-to-use all-in-one solution for the HORECA industry- GastroPlanner is one of Norway's leading suppliers of online tools for HORECA (hotels, restaurants, and catering). We offer a complete platform with all the tools and integrations needed to improve and streamline the daily operation of a HORECA business.

Exabel is an artificial intelligence startup based in Oslo, Norway. Exabel’s mission is to synthesize the world’s information and learn how it evolves. We are developing a smart digital assistant software tool for professional investment managers. We are currently a team of 6 full-time employees, with diverse backgrounds; two mathematicians, three software engineers, and a business developer. Combined, we have strong experience with companies like Google, Medallia, Arctic Securities, Intelligent Trading, Microsoft, and Brain Corporation. We are located in Forskningsparken, by StartupLab. The company is well funded for several years of research, product development, and market launch.

Nord-Norsk Elektro er en elektro- og kraftentreprenør etablert i 2012. Vi ønsker å være en entreprenørbedrift som er leverer kvalitet på alt fra små til større prosjekter. Nord-Norsk Elektro er en elektro- og kraftentreprenør etablert i 2012. Vi ønsker å være en entreprenørbedrift som er leverer kvalitet på alt fra små til større prosjekter. Primærområde vårt er Nord-Norge, men vi tar også på oss oppdrag i resten av landet. Vi har frihet til å søke nye spennende prosjekter innen våre kjerneområder, hvor gjennomføringsevne og samarbeid mellom oss, kunder og leverandører skal sørge for at felles mål og lønnsomhet i prosjektene nås. Hardt arbeid og kvalitetsbevissthet skal gjøre oss markedsledende innenfor våre fagområder. Vi leier også ut kompetanse til andre entreprenører og kraftselskaper ved behov.

Vimond provides online streaming software and services for broadcasters and content providers worldwide. Our local team counts 62 people from 17 nations, of which a majority are developers with a strong passion and expertise in online video workflows and innovative software and web development. As we continue to grow our team, we are always looking for people with relevant experience in media technology, software development, product development, system administration & dev ops, tech team lead roles, project management, account management, and solution architect roles. Contact us for an informal chat!

The List Media is the publisher of The List magazine, Trondheim's first and only English-language magazine, and the region's premier culture publication. The List magazine is a quarterly print publication, free and available from many different spots around town, including aboard the airport buses, all major hotels, the international schools, NTNU, SiT, Trondheim Havn, bars, cafes, SINTEF, Statoil and more. The List magazine is produced in collaboration with Trondheim kommune, Trondheimsregionen, and NTNU, plus many other advertising partners. The List Media also publishes a range of special editions about everything from science and technology to food and drink. The List media also produces print products and marketing materials for private customers.